OncoCareLine

After-hours cancer care when you need it

Helotes, Texas, United States

OncoCareLine is a telehealth service specializing in after-hours medical support for cancer patients, operating from 6 to 11 PM US Central standard time. It offers direct-to-consumer consultations and institutional partnerships to provide after-hours oncology support to clinics and hospitals.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out OncoCareLine on @MedStartr Today OncoCareLine is a telehealth service specializing in after-hours medical support for cancer patients, operating from 6 to 11 PM US Central standard time. It offers direct-to-consumer consultations and institutional partnerships to provide after-hours oncology support to clinics and hospitals. #CancerOncology #TelehealthVirtualCare #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/TU6sF5Mxp_A

Get Involved in OncoCareLine

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Problem Statement

Cancer patients often lack access to specialized oncology support outside of standard business hours (8 AM-5 PM), leading to potential gaps in care and an increase in unnecessary emergency room visits for non-emergent issues.

Core Technology

Telehealth platform

Key Differentiators

Telehealth service specializing in after-hours medical support for cancer patients; Provides consultations from 6 to 11 PM US Central standard time; Offers sliding-scale pricing options for patients unable to pay; Offers free consultations to VA hospital patients and Department of Defense beneficiaries; Focuses on reducing unnecessary ER visits through triage protocols that distinguish urgent from emergent cases; Markets itself as supporting primary oncology teams rather than replacing them; Employs licensed healthcare professionals with oncology expertise

Clinical Focus

After-hours medical support; Active treatment side effects; Survivorship care; Caregiver assistance; Triage protocols

Company Info

Business Model: B2B2C
Founded: 2025
Website: oncocareline.com/

Disease Areas

Cancer & Oncology

Technologies

HIPAA-compliantTelehealth & Telemedicine

Clinical & IP

🔬

Clinical Validation

No published clinical trials or peer-reviewed outcomes data. Service provides symptom management and triage, not clinical research validated.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of OncoCareLine?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.